{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:40:35Z","timestamp":1785444035718,"version":"3.56.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["R01 NS120485"],"award-info":[{"award-number":["R01 NS120485"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["1192211"],"award-info":[{"award-number":["1192211"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003975","name":"Myotonic Dystrophy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"US Department of the Army","doi-asserted-by":"publisher","award":["HT9425-24-1-0191"],"award-info":[{"award-number":["HT9425-24-1-0191"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM132066"],"award-info":[{"award-number":["T32 GM132066"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016471","name":"Agios Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031745","name":"Entrada Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"The Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtn.2024.102338","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T12:53:40Z","timestamp":1726232020000},"page":"102338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-8105","authenticated-orcid":false,"given":"Sawyer M.","family":"Hicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus A.","family":"Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek R.","family":"Muscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102338_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/brv.12674","article-title":"The hallmarks of myotonic dystrophy type 1 muscle dysfunction","volume":"96","author":"Ozimski","year":"2021","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.omtn.2024.102338_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102338_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/355547a0","article-title":"Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy","volume":"355","author":"Buxton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102338_bib4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene","volume":"255","author":"Mahadevan","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102338_bib5","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"Fu","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102338_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.omtn.2024.102338_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2014.03.039","article-title":"RNA-protein interactions in unstable microsatellite diseases","volume":"1584","author":"Mohan","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.omtn.2024.102338_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4939-1221-6_10","article-title":"RNA-binding protein misregulation in microsatellite expansion disorders","volume":"825","author":"Goodwin","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtn.2024.102338_bib9","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","article-title":"Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons","volume":"13","author":"Jiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib10","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.RES.0000193598.89753.e3","article-title":"Nuclear RNA foci in the heart in myotonic dystrophy","volume":"97","author":"Mankodi","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2024.102338_bib11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/ddl132","article-title":"Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy","volume":"15","author":"Lin","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/hmg\/11.7.805","article-title":"Three proteins, MBNL, MBLL and MBXL, co-localize in\u00a0vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells","volume":"11","author":"Fardaei","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/srep00209","article-title":"CUGBP1 and MBNL1 preferentially bind to 3' UTRs and facilitate mRNA decay","volume":"2","author":"Masuda","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102338_bib14","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1523\/JNEUROSCI.2352-16.2016","article-title":"Dysregulation of mRNA Localization and Translation in Genetic Disease","volume":"36","author":"Wang","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2024.102338_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","article-title":"Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease","volume":"56","author":"Batra","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102338_bib16","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.1038\/srep09042","article-title":"Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms","volume":"5","author":"Dixon","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102338_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"Mankodi","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102338_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102338_bib20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/hmg\/9.8.1185","article-title":"Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability","volume":"9","author":"Seznec","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bbadis.2007.08.004","article-title":"DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice","volume":"1772","author":"Guiraud-Dogan","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102338_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2010.03.006","article-title":"Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway","volume":"20","author":"Vignaud","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2024.102338_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0796-316","article-title":"Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice","volume":"13","author":"Jansen","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ng0796-325","article-title":"Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy","volume":"13","author":"Reddy","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/75500","article-title":"Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts","volume":"25","author":"Sarkar","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib26","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/hmg\/ddh266","article-title":"Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy","volume":"13","author":"O'Cochlain","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib27","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI32308","article-title":"Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy","volume":"117","author":"Wang","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102338_bib28","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/nar\/gkab022","article-title":"Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy","volume":"49","author":"Tanner","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102338_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molmed.2011.05.004","article-title":"Myotonic dystrophy mouse models: towards rational therapy development","volume":"17","author":"Gomes-Pereira","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2024.102338_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24129820","article-title":"Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSA(LR) Mice","volume":"24","author":"Alvarez-Abril","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102338_bib31","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.1901484116","article-title":"Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model","volume":"116","author":"Angelbello","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102338_bib32","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddn301","article-title":"Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin","volume":"17","author":"Banks","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib33","doi-asserted-by":"crossref","first-page":"25203","DOI":"10.1073\/pnas.1820297116","article-title":"Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in\u00a0vitro and in\u00a0vivo models","volume":"116","author":"Bargiela","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102338_bib34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41598-023-27661-w","article-title":"Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice","volume":"13","author":"Bargiela","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102338_bib35","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1093\/hmg\/ddv219","article-title":"Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy","volume":"24","author":"Bisset","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI89616","article-title":"Targeting deregulated AMPK\/mTORC1 pathways improves muscle function in myotonic dystrophy type I","volume":"127","author":"Brockhoff","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102338_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.omtn.2021.07.017","article-title":"Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy","volume":"26","author":"Cerro-Herreros","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102338_bib38","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.omtn.2020.07.021","article-title":"Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy","volume":"21","author":"Cerro-Herreros","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102338_bib39","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41467-018-04892-4","article-title":"miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models","volume":"9","author":"Cerro-Herreros","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102338_bib40","article-title":"Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102338_bib41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ebiom.2015.07.028","article-title":"Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation","volume":"2","author":"Choi","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2024.102338_bib42","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/hmg\/ddaa111","article-title":"Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features","volume":"29","author":"Crawford Parks","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib43","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1113\/jphysiol.2012.246546","article-title":"Age-dependent chloride channel expression in skeletal muscle fibres of normal and HSA(LR) myotonic mice","volume":"591","author":"DiFranco","year":"2013","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtn.2024.102338_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.09.001","article-title":"Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression","volume":"34","author":"Gonzalez-Martinez","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102338_bib45","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/hmg\/ddw042","article-title":"A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle","volume":"25","author":"Gudde","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12967-022-03806-9","article-title":"Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA(LR) mouse models","volume":"20","author":"Huang","year":"2022","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtn.2024.102338_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/acsptsci.9b00020","article-title":"Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 Models","volume":"2","author":"Jenquin","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.omtn.2024.102338_bib48","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1172\/JCI64081","article-title":"GSK3beta mediates muscle pathology in myotonic dystrophy","volume":"122","author":"Jones","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102338_bib49","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1073\/pnas.0604970103","article-title":"Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy","volume":"103","author":"Kanadia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102338_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2415","article-title":"CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model","volume":"12","author":"Ketley","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2024.102338_bib51","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddi223","article-title":"Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1","volume":"14","author":"Kimura","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib52","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1172\/JCI128205","article-title":"Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice","volume":"129","author":"Klein","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102338_bib53","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/srep02242","article-title":"Ultrasound-enhanced delivery of morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice","volume":"3","author":"Koebis","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102338_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2012.0404","article-title":"Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy","volume":"23","author":"Leger","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2024.102338_bib55","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1073\/pnas.1907297117","article-title":"HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102338_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1085\/jgp.200609635","article-title":"Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy","volume":"129","author":"Lueck","year":"2007","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.omtn.2024.102338_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310650","article-title":"Therapeutic Targeting of the GSK3beta-CUGBP1 Pathway in Myotonic Dystrophy","volume":"24","author":"Lutz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102338_bib58","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1113\/JP277123","article-title":"Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice","volume":"597","author":"Manta","year":"2019","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtn.2024.102338_bib59","article-title":"Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy","author":"Mishra","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2024.102338_bib60","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/mus.21988","article-title":"Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy","volume":"43","author":"Moyer","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2024.102338_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043794","article-title":"Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model","volume":"24","author":"Neault","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102338_bib62","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-1-4939-8651-4_30","article-title":"Exon Skipping by Ultrasound-Enhanced Delivery of Morpholino with Bubble Liposomes for Myotonic Dystrophy Model Mice","volume":"1828","author":"Negishi","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102338_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/gtc.12201","article-title":"ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1","volume":"20","author":"Ohsawa","year":"2015","journal-title":"Gene Cell."},{"key":"10.1016\/j.omtn.2024.102338_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041118","article-title":"BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA(LR) Mice","volume":"15","author":"Overby","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2024.102338_bib65","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1093\/hmg\/ddy245","article-title":"Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles","volume":"27","author":"Ravel-Chapuis","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102338_bib66","doi-asserted-by":"crossref","first-page":"20991","DOI":"10.1073\/pnas.1901893116","article-title":"A CTG repeat-selective\u00a0chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels","volume":"116","author":"Reddy","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102338_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2023.100667","article-title":"Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model","volume":"47","author":"Sabater-Arcis","year":"2024","journal-title":"Biomed. J."},{"key":"10.1016\/j.omtn.2024.102338_bib68","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/mus.26709","article-title":"Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1","volume":"60","author":"Sharp","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2024.102338_bib69","article-title":"Integrative proteogenomics for differential expression and splicing variation in a DM1 mouse model","author":"Solovyeva","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2024.102338_bib70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-0716-2772-3_13","article-title":"Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy","volume":"2587","author":"Stoodley","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102338_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00155-19","article-title":"Correction of Glycogen Synthase Kinase 3beta in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice","volume":"39","author":"Wang","year":"2019","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102338_bib72","article-title":"GSK3beta is a new therapeutic target for myotonic dystrophy type 1","volume":"1","author":"Wei","year":"2013","journal-title":"Rare Dis."},{"key":"10.1016\/j.omtn.2024.102338_bib73","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.201700700R","article-title":"Correction of GSK3beta at young age prevents muscle pathology in mice with myotonic dystrophy type 1","volume":"32","author":"Wei","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2024.102338_bib74","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.celrep.2015.11.028","article-title":"Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models","volume":"13","author":"Siboni","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2024.102338_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in\u00a0vivo correction of myotonic dystrophy","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102338_bib76","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41596-023-00944-2","article-title":"rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data","volume":"19","author":"Wang","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2024.102338_bib77","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr1291","article-title":"MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data","volume":"40","author":"Shen","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102338_bib78","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11752","article-title":"A new view of transcriptome complexity and regulation through the lens of local splicing variations","volume":"5","author":"Vaquero-Garcia","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2024.102338_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/00221300309601282","article-title":"A Monte Carlo evaluation of tests for comparing dependent correlations","volume":"130","author":"Hittner","year":"2003","journal-title":"J.\u00a0Gen. Psychol."},{"key":"10.1016\/j.omtn.2024.102338_bib80","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2024.102338_bib81","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/nprot.2016.095","article-title":"Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown","volume":"11","author":"Pertea","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2024.102338_bib82","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2024.102338_bib83","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2024.102338_bib84","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102338_bib85","unstructured":"Iqbal, A., Duitama, C., Metge, F., Rosskopp, D.,\u00a0& Boucas, J. (2021). Flaski (2.0.0)."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:16:02Z","timestamp":1764177362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2162253124002257"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102338","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102338"}}